Please use this identifier to cite or link to this item: https://doi.org/10.1186/s12955-020-01493-y
Title: Psychometric testing of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group - Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy
Authors: Cheng, H.L.
Lopez, V. 
Lam, S.C.
Leung, A.K.T.
Li, Y.C.
Wong, K.H.
Au, J.S.K.
Sundar, R.
Chan, A. 
De Ng, T.R.
Suen, L.K.P.
Chan, C.W.
Yorke, J.
Molassiotis, A.
Keywords: Chemotherapy
Confirmatory factor analysis
EORTC QLQ-CIPN20
FACT/GOG-Ntx
Peripheral neuropathy
Psychometrics
Responsiveness
Issue Date: 2020
Publisher: BioMed Central
Citation: Cheng, H.L., Lopez, V., Lam, S.C., Leung, A.K.T., Li, Y.C., Wong, K.H., Au, J.S.K., Sundar, R., Chan, A., De Ng, T.R., Suen, L.K.P., Chan, C.W., Yorke, J., Molassiotis, A. (2020). Psychometric testing of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group - Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy. Health and Quality of Life Outcomes 18 (1) : 246. ScholarBank@NUS Repository. https://doi.org/10.1186/s12955-020-01493-y
Rights: Attribution 4.0 International
Abstract: Background: The aim of this study was to evaluate the psychometric properties of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group - Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy. Methods: Patients were assessed with the FACT/GOG-Ntx subscale, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Chemotherapy-Induced Peripheral Neuropathy Scale 20 (EORTC QLQ-CIPN20), National Cancer Institute -Common Terminology Criteria for Adverse Events (NCI-CTCAE), and light touch test using 10 g monofilament for up to ten assessment points from baseline (prior to initiation of first chemotherapy), after the end of each cycle (up to 6 cycles, 3 weeks per cycle), and at 6, 9, and 12 months after starting chemotherapy. Psychometric analyses included internal consistency reliability, convergent validity, factorial validity, sensitivity to change and responsiveness (minimal clinically important difference, MCID). Results: Cronbach's alpha coefficients of the FACT/GOG-Ntx subscale were 0.82-0.89 across assessment points. The subscale strongly correlated with the EORTC QLQ-CIPN20 (r = 0.79-0.93) but low-to-moderately correlated with the NCI-CTCAE sensory (r s = 0.23-0.45) and motor items (r s = 0.15-0.50) as well as the monofilament test (r s = 0.23-0.47). The hypothesized 4-factor structure of the FACT/GOG-Ntx subscale was not confirmed at assessment points (?2/df = 2.26-8.50; all P < 0.001). The subscale exhibited small-to-moderate sensitivity to change (r = 0.17-0.37). The MCIDs were between 1.38 and 3.68. Conclusion: The FACT/GOG-Ntx subscale has satisfactory reliability, validity, sensitivity to change and responsiveness to evaluate CIPN in cancer patients. Future research is needed to explore the factorial structure of the FACT/GOG-Ntx subscale as the published four-factor structure was not supported in this study. © 2020 The Author(s).
Source Title: Health and Quality of Life Outcomes
URI: https://scholarbank.nus.edu.sg/handle/10635/199768
ISSN: 1477-7525
DOI: 10.1186/s12955-020-01493-y
Rights: Attribution 4.0 International
Appears in Collections:Staff Publications
Elements

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1186_s12955_020_01493_y.pdf561.51 kBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons